Gene · 4016
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive bioinformatics analysis of the expression, prognostic value, and immune infiltration of chromobox family members in cervical cancer. | Iran J Basic Med Sci | 2023 | 37009012 | PubTator, text mining | PubMed |
| Targeting the next generation of gamblers? Gambling sponsorship of esports teams. | J Public Health (Oxf) | 2023 | 37000185 | PubTator, text mining | PubMed |
| Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma. | Front Genet | 2023 | 36999053 | PubTator, text mining | PubMed |
| Cholesterol-Related lncRNAs as Response Predictors of Atorvastatin Treatment in Chilean Hypercholesterolemic Patients: A Pilot Study. | Biomedicines | 2023 | 36979720 | PubTator, text mining | PubMed |
| Long noncoding RNAs with peptide-encoding potential identified in esophageal squamous cell carcinoma: KDM4A-AS1-encoded peptide weakens cancer cell viability and migratory capacity. | Mol Oncol | 2023 | 36965032 | PubTator, text mining | PubMed |
| Influence of clusterin genetic variants on IOP elevation in pseudoexfoliation syndrome and pseudoexfoliative glaucoma in Turkish population. | BMC Ophthalmol | 2023 | 36959561 | PubTator, text mining | PubMed |
| Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies. | Nat Commun | 2023 | 36932114 | PubTator, text mining | PubMed |
| Roles of lncRNAs in childhood cancer: Current landscape and future perspectives. | Front Oncol | 2023 | 36923440 | PubTator, text mining | PubMed |
| Emerging role of miRNAs, lncRNAs, and circRNAs in pregnancy-associated diseases. | Chin Med J (Engl) | 2023 | 36914956 | PubTator, text mining | PubMed |
| LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells. | Front Oncol | 2023 | 36910659 | PubTator, text mining | PubMed |
| New insights into fibrotic signaling in renal cell carcinoma. | Front Cell Dev Biol | 2023 | 36910160 | PubTator, text mining | PubMed |
| Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy. | Front Physiol | 2023 | 36909247 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers. | Int J Mol Sci | 2023 | 36902032 | PubTator, text mining | PubMed |
| Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors. | Cancers (Basel) | 2023 | 36900328 | PubTator, text mining | PubMed |
| Twenty Novel MicroRNAs in the Aqueous Humor of Pseudoexfoliation Glaucoma Patients. | Cells | 2023 | 36899874 | PubTator, text mining | PubMed |
| Comparison between articular chondrocytes and mesenchymal stromal cells for the production of articular cartilage implants. | Front Bioeng Biotechnol | 2023 | 36896010 | PubTator, text mining | PubMed |
| Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization. | Nat Commun | 2023 | 36894533 | PubTator, text mining | PubMed |
| Light and electron microscopic features of preclinical pseudoexfoliation syndrome. | PLoS One | 2023 | 36893133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4016/papers?page=13